HARVARD BIOSCIENCE INC — Director's Dealing 2015

Jun 10, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2015-06-09

Reporting Person: LEWIS EARL R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-09	Common Stock	M	7070	$2.56	Acquired	333878	Direct
2015-06-09	Common Stock	M	3301	$3.71	Acquired	337179	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-09	Stock option (right to buy)	$2.56	M	7070	Disposed	2022-06-01	Common stock, par value $0.01 per share (7070)	Direct
2015-06-09	Stock option (right to buy)	$3.71	M	3301	Disposed	2017-05-24	Common stock, par value $0.01 per share (3301)	Direct

Footnotes

F1: Includes (a) a deferred stock award of 14,400 restricted stock units which fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 4, 2015, immediately prior to the commencement of such meeting, and (ii) June 4, 2016.; and (b) 319,478 shares of common stock held by the Reporting Person.

F2: Includes (a) a deferred stock award of 14,400 restricted stock units which fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 4, 2015, immediately prior to the commencement of such meeting, and (ii) June 4, 2016.; and (b) 322,779 shares of common stock held by the Reporting Person.

F3: Represents exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended.

F4: The options vested in three equal installments of June 1, 2013, 2014 and 2015.

F5: The options vested in three equal installments of May 24, 2008, 2009 and 2010.